Michael P. Stansky's most recent trade in TriSalus Life Sciences Inc was a trade of 243,900 Common Stock done at an average price of $4.1 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TriSalus Life Sciences Inc | Michael P. Stansky | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 23 Feb 2026 | 243,900 | 787,132 | - | 4.1 | 999,990 | Common Stock |
| TriSalus Life Sciences Inc | Michael P. Stansky | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 23 Feb 2026 | 117,198 | 199,698 | - | 4.1 | 480,512 | Common Stock |
| TriSalus Life Sciences Inc | Michael P. Stansky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 92,537 | 92,537 | - | - | Director Stock Option (right to buy) |